FDA Warns Florida Contract Manufacturer for Cleaning, Testing Issues

Drug Industry Daily
A A
Fort Lauderdale contract drug manufacturer ANDAPharm drew a warning letter from the FDA for repeat cleaning deficiencies, inadequate stability protocols and other serious problems.

To View This Article:

Login

Subscribe To Drug Industry Daily